Using a combination of urine and plasma biomarkers for the development of a scoring sytem that can diagnose and predict prognosis of prostate cancer.
Maher Albitar
Employment or Leadership Position - NeoGenomics Laboratories
Stock Ownership - NeoGenomics Laboratories
Wanlong Ma
Employment or Leadership Position - NeoGenomics Laboratories
Stock Ownership - NeoGenomics Laboratories
Kevin Diep
Employment or Leadership Position - NeoGenomics Laboratories
Ferras S. Albitar
Employment or Leadership Position - NeoGenomics Laboratories
Herbert A. Fritsche
No relevant relationships to disclose
Neal D. Shore
No relevant relationships to disclose